PEPG Q4 2024 Earnings — PepGen Inc. Revenue & Financial Results | Market Cap Arena

PEPGPepGen Inc.

$435M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$380,000

Operating Income

-$24M

Net Income

-$22M

EPS (Diluted)

$-0.68

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$20M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$151M

Total Liabilities

$32M

Stockholders' Equity

$119M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$380,000	-$354,000	-7.3%
Operating Income	-$24M	-$21M	-17.0%
Net Income	-$22M	-$19M	-14.1%